PGS9- THE COST-EFFECTIVENESS OF HIGH DOSE ORAL VERSUS INTRAVENOUS PROTON PUMP INHIBITION IN HIGH-RISK PATIENTS WITH BLEEDING PEPTIC ULCERS HAVING UNDERGONE THERAPEUTIC ENDOSCOPY
May 1, 2003, 00:00
10.1016/S1098-3015(10)63972-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)63972-1/fulltext
Title :
PGS9- THE COST-EFFECTIVENESS OF HIGH DOSE ORAL VERSUS INTRAVENOUS PROTON PUMP INHIBITION IN HIGH-RISK PATIENTS WITH BLEEDING PEPTIC ULCERS HAVING UNDERGONE THERAPEUTIC ENDOSCOPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63972-1&doi=10.1016/S1098-3015(10)63972-1
First page :
Section Title :
Open access? :
No
Section Order :
173